{
    "code": "02024521",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024521",
    "time": "2016-07-15 05:58:53",
    "許可證字號": "衛署藥輸字第024521號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/09\/05",
    "發證日期": "95\/09\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202452101",
    "中文品名": "雅脈加強錠20\/25毫克",
    "英文品名": "Olmetec Plus 20\/25mg, film coated tablets",
    "適應症": "治療原發性高血壓。Olmetec Plus固定劑量複合劑療法適用於服用Olmesartan medoxomil單方無法有效控制血壓的高血壓病患。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
    "限制項目": [
        "02輸入",
        "58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥"
    ],
    "申請商名稱": "620117E518  台灣第一三共股份有限公司",
    "申請商地址": "台北市中山區八德路二段308號7樓之1",
    "主製造廠": {
        "製造廠名稱": "F470135000  DAIICHI SANKYO EUROPE GMBH",
        "製造廠廠址": "LUITPOLDSTRABE 1 D-85276 PFAFFENHOFEN, GERMANY",
        "製造廠公司地址": "ZIELSTATTSTRABE 48, 81379 MUNICH, GERMANY",
        "製造廠國別": "GERMANY",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005910",
            "成分名稱": "OLMESARTAN MEDOXOMIL",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4028100600",
            "成分名稱": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020245210001-105-03-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024521&Seq=004&Type=9"
        },
        {
            "title": "Olmetec plus E leaflet_approval version_頁面_1 (2 files merged)-104-07-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024521&Seq=003&Type=9"
        },
        {
            "title": "Olmetec plus C leaflet_approval version_頁面_1 (2 files merged)-104-07-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024521&Seq=002&Type=9"
        },
        {
            "title": "020245210001-104-07-18.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024521&Seq=001&Type=9"
        }
    ]
}